Zbigniew Gaciong Selected Research

n-dodecane

8/2021

Familial SDHB gene mutation in disseminated non-hypoxia-related malignant paraganglioma treated with [90Y]Y/[177Lu]Lu- DOTATATE.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zbigniew Gaciong Research Topics

Disease

17	Hypertension (High Blood Pressure) 01/2022 - 02/2004
5	Aortic Valve Stenosis (Aortic Stenosis) 01/2020 - 09/2002
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 04/2010
4	Neoplasms (Cancer) 02/2019 - 08/2006
3	Inflammation (Inflammations) 01/2021 - 01/2003
3	Hyperaldosteronism (Conn Syndrome) 01/2021 - 01/2017
3	Atrial Fibrillation 01/2018 - 08/2011
3	Cardiomegaly (Heart Hypertrophy) 01/2017 - 07/2004
3	Hypertrophy 01/2017 - 09/2002
3	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2017 - 09/2002
3	Stroke (Strokes) 12/2013 - 04/2010
3	Myocardial Infarction 04/2010 - 01/2003
2	Neoplasm Metastasis (Metastasis) 08/2021 - 02/2019
2	Aneurysm (Aneurysms) 03/2020 - 01/2018
2	Chronic Renal Insufficiency 01/2016 - 01/2012
2	Fibrosis (Cirrhosis) 01/2014 - 09/2007
2	Arteriovenous Fistula 01/2012 - 02/2004
2	Essential Hypertension 05/2011 - 01/2006
2	Hypercholesterolemia 10/2010 - 03/2008
2	Heart Failure 04/2010 - 04/2010
2	Glucose Intolerance 04/2010 - 04/2010
2	Unstable Angina 04/2010 - 04/2010
2	Proteinuria 05/2007 - 02/2004
2	Pheochromocytoma 08/2006 - 08/2006
1	Paraganglioma (Paragangliomas) 08/2021
1	Hypokalemia 01/2021
1	Infections 01/2020
1	Carcinoma (Carcinomatosis) 02/2019
1	Colonic Neoplasms (Colon Cancer) 02/2019
1	Colorectal Neoplasms (Colorectal Cancer) 02/2019
1	Abdominal Aortic Aneurysm 01/2018
1	Hypoxia (Hypoxemia) 01/2017
1	Venous Thromboembolism 01/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017
1	Hemorrhage 01/2017
1	Atherosclerosis 01/2016
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 01/2016
1	Coronary Disease (Coronary Heart Disease) 01/2016

Drug/Important Bio-Agent (IBA)

6	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 10/2004
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 03/2008
3	PotassiumIBA 01/2019 - 01/2017
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2017 - 10/2004
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2004 - 09/2002
2	CytokinesIBA 01/2021 - 01/2003
2	oxidized low density lipoproteinIBA 01/2020 - 01/2016
2	CreatinineIBA 01/2019 - 05/2011
2	SodiumIBA 01/2019 - 01/2018
2	CholesterolIBA 01/2016 - 03/2008
2	LipidsIBA 01/2016 - 04/2012
2	Angiotensin IIIBA 01/2014 - 09/2007
2	Proteins (Proteins, Gene)FDA Link 05/2011 - 08/2006
2	AlbuminsIBA 05/2011 - 05/2007
2	Valsartan (Vals)FDA Link 04/2010 - 04/2010
2	Nateglinide (Starlix)FDA LinkGeneric 04/2010 - 04/2010
2	Atorvastatin (Lipitor)FDA Link 06/2009 - 03/2008
2	CatecholaminesIBA 08/2006 - 08/2006
1	Bisoprolol (Concor)FDA LinkGeneric 01/2022
1	Amlodipine (Norvasc)FDA LinkGeneric 01/2022
1	n-dodecaneIBA 08/2021
1	AcidsIBA 08/2021
1	EnzymesIBA 08/2021
1	Radioisotopes (Radionuclides)IBA 08/2021
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 08/2021
1	Peptide Receptors (Peptide Receptor)IBA 08/2021
1	Opioid Analgesics (Opioids)IBA 04/2021
1	AldosteroneIBA 01/2021
1	Hyaluronic Acid (Hyaluronan)IBA 01/2021
1	ReninIBA 01/2021
1	Mineralocorticoid Receptor AntagonistsIBA 01/2021
1	evolocumabIBA 01/2020
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2020
1	Proprotein Convertase 9IBA 01/2020
1	LigandsIBA 02/2019
1	Chemokine CCL7IBA 02/2019
1	CCR2 ReceptorsIBA 02/2019
1	CC ChemokinesIBA 02/2019
1	Immunoglobulins (Immunoglobulin)IBA 02/2019
1	ChemokinesIBA 02/2019
1	Dietary SodiumIBA 01/2019
1	Plasma Membrane Calcium-Transporting ATPasesIBA 01/2017
1	Drug CombinationsIBA 01/2017
1	Angiotensin II Type 1 Receptor BlockersIBA 01/2017
1	AnticoagulantsIBA 01/2017
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	Flavin-Adenine Dinucleotide (FAD)IBA 01/2017
1	RivaroxabanIBA 01/2017
1	renalaseIBA 01/2017
1	apixabanIBA 01/2017
1	edoxabanIBA 01/2017
1	CalciumIBA 01/2017
1	Dabigatran FDA Link 01/2017
1	SmokeIBA 01/2016
1	HDL CholesterolIBA 01/2016
1	PCSK9 InhibitorsIBA 01/2016
1	Oxygen (Dioxygen)IBA 09/2014
1	Chymases (Chymase)IBA 01/2014

Therapy/Procedure

10	Therapeutics 01/2022 - 06/2003
3	Drug Therapy (Chemotherapy) 01/2022 - 11/2010
2	Endovascular Aneurysm Repair 03/2020 - 01/2018
2	Electric Countershock (Cardioversion) 01/2018 - 08/2011